Atara Biotherapeutics (ATRA) Enterprise Value Growth (1y) (2014 - 2026)
Atara Biotherapeutics (ATRA) Enterprise Value Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Atara Biotherapeutics |
137.85 Mn |
129.45 Mn |
392,000.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
39.31% |
| Dec 31, 2025 |
66.24% |
| Sep 30, 2025 |
79.59% |
| Jun 30, 2025 |
52.11% |
| Mar 31, 2025 |
60.72% |
| Dec 31, 2024 |
51.33% |
| Sep 30, 2024 |
-3.47% |
| Jun 30, 2024 |
23.35% |
| Mar 31, 2024 |
27.93% |
| Dec 31, 2023 |
78.70% |
| Sep 30, 2023 |
75.53% |
| Jun 30, 2023 |
36.08% |
| Mar 31, 2023 |
51.98% |
| Dec 31, 2022 |
34.56% |
| Sep 30, 2022 |
-134.04% |
| Jun 30, 2022 |
80.71% |
| Mar 31, 2022 |
32.70% |
| Dec 31, 2021 |
25.88% |
| Sep 30, 2021 |
65.34% |
| Jun 30, 2021 |
-399.81% |
